EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rupatadine Ameliorates Cisplatin‐Induced Hepatotoxicity in Rats: Targeting HMGB1/TLR4/NF‐κB and NLRP3/Caspase‐1 Signaling Pathways

Shaimaa Mohamed Abdelrahman, Amany Abdlrehim Bekhit, Olivia N Beshay iD

Journal of Biochemical and Molecular Toxicology · 2026-08 · 40 (8)

DOI: 10.1002/jbt.71050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 30.07.2026. Verfasst von Shaimaa Mohamed Abdelrahman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, HMGB1 Protein, Signal Transduction, Caspase 1. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite cisplatin (CISP) is broadly employed in cancer therapy, its adverse effects, involving hepatotoxicity, restrict its clinical usage. Thus, this study was designed to explore the prospect of repurposing rupatadine (RUPA), a dual antagonist of histamine and platelet‐activating factor (PAF), against CISP‐evoked hepatotoxicity in rats. Rats were i.p . injected with CISP (6 mg/kg) for the induction of hepatotoxicity on the 8th day of the study in the presence and absence of RUPA in two dosages (3, 6 mg/kg) orally for 14 days. Different biochemical parameters and histopathological assessments, along with the mechanistic characterizations of the possible protective impact of the RUPA were conducted. Administration of CISP evoked hepatic histopathological modifications and raised serum liver enzyme levels and hepatic MDA content, PAF, and histamine levels, along with diminishing the serum albumin level, hepatic SOD activity, and GSH level. Moreover, CISP remarkably augmented the levels of HMGB1, TLR4, p‐NF‐κB p65, IL‐6, TNF‐α, IL‐18, IL‐1β, NLRP3, and cleaved caspase‐1 proteins with an evident decline in the level of IL‐10. On the contrary, pretreatment with either RUPA.3 or RUPA.6 dramatically ameliorated these alterations triggered by CISP injection. RUPA counteracts hepatotoxicity evoked by CISP in rats via its anti‐oxidative as well as anti‐inflammatory properties via repression of hepatic HMGB1/TLR4/NF‐κB and thus restricts the activation of NLRP3/caspase‐1 signaling cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinHMGB1 ProteinSignal TransductionCaspase 1Toll-Like Receptor 4CisplatinChemical and Drug Induced Liver InjuryNF-kappa BCyproheptadineAnimalsRatsMaleLiverRats, Wistar

Stichwörter der Autor:innen

HMGB1NLRP3PAFcisplatinhepatotoxicityrupatadine

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinHMGB1 ProteinNlrp3 protein, ratTlr4 protein, ratCaspase 1Toll-Like Receptor 4CisplatinNF-kappa BCyproheptadineHbp1 protein, rat

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Minia National University, New Minia, Egypt.

ORCID-Profile: Olivia N Beshay

Zitieren

APA

Abdelrahman, S. M., Bekhit, A. A., & Beshay, O. N. (2026). Rupatadine Ameliorates Cisplatin‐Induced Hepatotoxicity in Rats: Targeting HMGB1/TLR4/NF‐κB and NLRP3/Caspase‐1 Signaling Pathways. Journal of Biochemical and Molecular Toxicology, 40(8). https://doi.org/10.1002/jbt.71050

Vancouver

Abdelrahman SM, Bekhit AA, Beshay ON. Rupatadine Ameliorates Cisplatin‐Induced Hepatotoxicity in Rats: Targeting HMGB1/TLR4/NF‐κB and NLRP3/Caspase‐1 Signaling Pathways. Journal of Biochemical and Molecular Toxicology. 2026;40(8). doi:10.1002/jbt.71050

BibTeX
@article{Abdelrahman2026,
  author = {Abdelrahman, Shaimaa Mohamed and Bekhit, Amany Abdlrehim and Beshay, Olivia N},
  title = {Rupatadine Ameliorates Cisplatin‐Induced Hepatotoxicity in Rats: Targeting HMGB1/TLR4/NF‐κB and NLRP3/Caspase‐1 Signaling Pathways},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1002/jbt.71050}
}
Kostenlos starten →